Skip to content

Repetitive transcranial magnetic stimulation activates motor sequence learning to promote upper limb function after stroke

Repetitive transcranial magnetic stimulation activates motor sequence learning to promote upper limb function after stroke

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085022
Enrollment
Unknown
Registered
2024-05-29
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Control group:rTMS pseudostimulation + conventional rehabilitation
Stimulation Group 1 (Primary motor cortex,M1):rTMS acts on M1+ conventional rehabilitation
Stimulation Group 2(Supplementary Motor Area, SMA):rTMS acts on SMA+ conventional rehabilitation

Sponsors

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The diagnosis meets the diagnostic criteria for cerebrovascular disease formulated by the Chinese Medical Association in 2010 and is confirmed by CT or MRI examination; (2) Patients with stable vital signs, first onset, and disease course within 2 years; (3) Mental clarity, upper limb muscle strength = grade 3, muscle tone = grade 1+, Brunnstrom = grade 3; (4) Assessed by MMSE scale with greater than or equal to 20 points, cognitive ability cooperation test; (5) Sitting balance level 2 or above; (6) Patients who have been informed about the experiment and agree to participate in the experiment after publicity and mobilization; (7) Visual acuity/normal visual acuity after correction, and assessment and training can be completed

Exclusion criteria

Exclusion criteria: (1) Patients with cognitive impairment and mental disorders;  (2) Patients with contraindications to transcranial magnetic (electrodes made of silver or gold in the skull, metal brain implants; The distance between the electronic components in the body and the TMS coil is less than 10cm; personal history of epilepsy or other factors that may lower the seizure threshold);  (3) Patients with severe comorbidities such as heart, liver, kidney, and brain failure; (4) Patients who have undergone or systematically rehabilitated before.

Design outcomes

Primary

MeasureTime frame
serial reaction time task,SRTT;ADL assessment:MB;Assessment of upper limb function:Fugl-Meyer;

Secondary

MeasureTime frame
Muscle tone rating :M Ashworth;Quality of life evaluation:SF-12;Emotional situation(HAMA,HAMD);Functional near-infrared spectroscopy (fNIRS) acquisition; motor evoked potentials;

Countries

China

Contacts

Public ContactGuangxu Xu

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

xuguangxu1@126.com+86 139 5173 1331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026